Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

DoD Vaccine Report Proposes Interdepartmental Group To Work With Industry

Executive Summary

The Department of Defense is recommending the development of an interdepartmental "executive council" that would advise the federal government on vaccine planning and serve as the primary point of contact with vaccine manufacturers on procurement

You may also be interested in...



Vaccine Facility Should Be Considered By Homeland Security Dept. – Ridge

The Department of Homeland Security should consider collaborating with HHS and the Department of Defense to establish a government-owned, contractor-operated vaccine production facility, Office of Homeland Security Director Tom Ridge said

Anthrax Vaccine Stockpile For Civilians Created From Half Of BioPort Output

A joint DoD/HHS effort to reinstate the military Anthrax Vaccination Immunization Program will set aside roughly half of produced vaccine to increase emergency civilian stockpiles

Bioterrorism Vaccines: Liability Limits, Federalization Under Consideration

The Biotechnology Industry Organization is urging Congress to limit the liability of manufacturers who enter the vaccine production business in the interest of preparedness against potential bioterrorism attacks.

Latest Headlines
See All
UsernamePublicRestriction

Register

PS040259

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel